OVERVIEW

The Evolution of HCT, Part 4: Addressing Barriers is organized by Medical Learning Institute, LLC.

Release Date: Feb 22, 2024
Expiration Date: Feb 21, 2025

Activity Description:
Community hematology/oncology practices play a critical role to expand patient access to hematopoietic cell transplantation (HCT) and improve patient outcomes.

This self-guided online training course series consists of five courses designed to present the current state of the science for Hematopoietic Cell Transplantation (HCT) by following the evolution of HCT over time. The series is broken down into major misperceptions or myths about HCT and cellular therapy that are not supported by current research and clinical practice.

This is Part 4 in a 5-part series, examining major barriers to HCT and ways to overcome them.

Educational Objectives:
After completing this activity, the participant should be better able to:

  • Implement strategies to overcome concerns about barriers to HCT and how to address them.
  • Discuss psychosocial barriers and access challenges in HCT.
  • Examine trends in racial and ethnic disparities in HCT.
  • Describe referral trends and biases in HCT that can limit access to care.

Program Agenda:

  • Overcoming Concerns, Part 4: Barriers to Transplant
  • Psychosocial Barriers and HCT Access
  • Disparities in Transplant
  • Referral Trends and Bias
Credits

Accreditation, Support and Credit
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., and NMDP. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 0.5 contact hour and no contact hour in the area of pharmacology.

Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credit for learning and change.

  • 0.5 AMA PRA Category 1 Credit™
  • 0.5 Contact Hours
  • 0.5 IPCE
  • TARGET AUDIENCE

    PhysicianNursingOncologistsHematologistAdvanced Practice Providers

    SPECIALITIES

    HematologyOncology

    RELATED ONLINE COURSES

    May 25, 2022 - Nov 30, 2026 | Webcast

    State required course for Connecticut ...
    5 AMA PRA Category 1 Credits™
    ...
    More actions
    US$180

    Aug 23, 2022 - Nov 30, 2026 | Webcast

    State required course for New Jersey
    3 AMA PRA Category 1 Credits™
    ...
    More actions
    US$15.20